Aligos Therapeutics ALGS 深 沪
等待开盘 07-22 09:30:00 美东时间
8.64
-0.520
-5.68%
华盛通- 最 高9.92
- 今 开9.24
- 成交量 17.07万股
- 最 低 8.64
- 昨 收 9.16
- 总市值 5283.19万
- 52周最高 46.80
- 市盈率 静 --
- 换手率 2.79%
- 52周最低 3.76
- 委 比 -60.60%
- 总股本 611.48万
- 历史最高 937.75
- 量 比 2.29
- 振 幅 13.97%
- 历史最低 3.76
- 每 手 1
- 风险率 9.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
Aligos Therapeutics has appointed Kieron Wesson, PhD, as Vice President and Head of Chemistry, Manufacturing, and Controls (CMC). Wesson brings over 20 years of experience in pharmaceutical development and will oversee all CMC-related matters, including the upcoming Phase 2 study of ALG-000184. Previously, he held leadership roles at Kezar Life Sciences, AN2 Therapeutics, and Anacor Pharmaceuticals. Aligos, a clinical-stage biotech company specia...
06-18 12:00
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p>Aligos Therapeutics授予26,000股股票期权给新员工，作为入职激励。期权基于公司2024年激励计划，授予日为2025年6月10日，行权价为当日收盘价。股票分四年 vesting，25%在第一年，剩余部分按月分摊。公司致力于开发肝脏和病毒疾病的最佳疗法。</p>
06-13 12:00
“北京普惠健康保”特药清单扩容，涵盖肿瘤等121种国内及海外药品
转自：北京日报客户端 为进一步提升药品保障待遇，减轻参保人用药负担，2025年度“北京普惠健康保”特药清单重磅升级，特药清单由106种升级至121种。新版特药...
06-10 10:33
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
Aligos Therapeutics的管理层将于6月5日在Jefferies Global Healthcare Conference上发表演讲，投资者可通过公司官网观看直播及回放。公司专注于开发肝病和病毒性疾病的最佳疗法，涵盖慢性乙肝、MASH及冠状病毒等领域。
05-29 12:00
Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock
Throughout the last three months, 4 analysts have evaluated Mirum Pharmaceutica...
05-10 04:01
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeu...
03-14 20:00
美股大行评级 | 美银证券：维持雅培"买入"评级，目标价从133美元升至150美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM：维持CervoMed Inc.(CRVO)"买入"评级，目标价从7美元升至15美元</p> <p>• Oppenheimer：维持Trevi Therapeutics(TRVI)"跑赢大市"评级，目标价从
03-12 11:01
Aligos Therapeutics Advances Pipeline Amid Financial Challenges
Aligos Therapeutics, Inc. ( ($ALGS) ) has released its Q4 earnings. Here is a b...
03-11 11:55
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.
03-11 00:59
